Is This Going to Be Accelerated to Therapy?

This is a real powerhouse team, Chris Garcia, who's an expert in all things synthetic biology at Stanford. One thing you notice here is they didn't just use a system to target any old solid tumors. They targeted pancreatic cancer, and we know pancreatic cancer is one of the most lethal types of cancers out there. I think this is really tweaking this tool just in the run up to clinical trials, which I would guess are right around the corner.